Increased burden of disease and role of health economics: Asia-pacific region.,Expert Review of Pharmacoeconomics & Outcomes Research

当前位置： X-MOL 学术 › Expert Rev. Pharmacoecon. Outcomes Res. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Increased burden of disease and role of health economics: Asia-pacific region.
Expert Review of Pharmacoeconomics & Outcomes Research ( IF 1.8 ) Pub Date : 2019-08-14 , DOI: 10.1080/14737167.2019.1650643
Shahid Shah ₁ , Ghulam Abbas ₁ , Muhammad Hanif ₂ , Anees-Ur-Rehman ₃ , Muhammad Zaman ₄ , Nabeel Riaz ₁ , Arslan Altaf ₁ , Shams Ul Hassan ₁ , Usman Saleem ₁ , Abid Shah ₅

Affiliation

Background: Health-care systems in Asian countries are diverse. The economic evaluation provides information on how to make efficient use of the resources available to obtain the maximum benefits. In Asia, diseases such as cardiovascular diseases (CVDs), diabetes mellitus (DM), tuberculosis (TB) and epilepsy generate a heavy economic burden. The objective of this article is to provide a review of the economic burden of health to patients in Asian countries. Areas covered: All data were collected from already published research article and review papers. The databases searched were Science Direct, PubMed, MEDLINE and Google scholar. We found a total of 4456 articles on health economics. After reviewing the title, only 876 relevant articles were considered. Only 92 (n = 92) articles were considered on the basis of inclusion and exclusion criteria. Expert opinion: Available data give evidence that diseases are linked to the low socio-economic status of the Asian population. The cost per capita is high in Asian countries due to insufficient health-care facilities. The cost per capita in Asian countries ranges from $23 (Pakistan) to $1775 (Taiwan). The per capita cost of Malaysia, China, Singapore, and Thailand is $27 $83, $75, and $27, respectively.

更新日期：2019-11-01

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11